Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Private Equity Compliance Checklist

The complex and ever-changing healthcare regulatory and enforcement environment, including increased focus on the role of private equity firms in their portfolio companies, make compliance a top priority for private equity firms investing in healthcare companies. The best way to limit your exposure as a private equity firm is to avoid a compliance misstep in the first place. Additionally, an effective and robust compliance program for your portfolio healthcare company makes it much more attractive to potential buyers and helps you avoid an unexpected and costly investigation or valuation hit down the road. Download the Healthcare Private Equity Compliance Checklist to assess whether your portfolio company's compliance program is up-to-date.

Click here to download the checklist.

Shannon Wiley Comments on Legal Differences of Patient Drug Assistance Programs and Copay Coupons

Media Mentions

February 16, 2015

Bass, Berry & Sims attorney Shannon Wiley provided insight for an article outlining the impact that drug manufacturer funded programs have for patients receiving high cost drug therapies. In the article, Shannon discusses the legal differences between patient assistance programs (PAPs), typically for patients without insurance and "copay coupon" programs for those with insurance. As Shannon points out in the article "[t]here are legal requirements associated with providing both types of assistance. For example, 'copay coupons are not available to patients with insurance under a federal program, such as Medicare Part D.'" Shannon also addresses contractual payor prohibitions of copay coupon use, "'[m]any specialty pharmacies don't have the leverage to keep copay coupon prohibitions out of payor agreements so the real issue for SPs is to establish a protocol to honor the prohibition.'"

The full article, "PAPs Offer Safety Net for Soaring Drug Prices," was published in the February 2015 issue of Specialty Pharmacy Continuum and is available online to subscribers.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.